Singapore markets open in 1 hour 10 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
59,134.13 +806.66 (+1.38%) CMC Crypto 200
1,275.53 +4.79 (+0.38%)
Sangamo Therapeutics, Inc. (SGMO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.5438 |
| Open | 0.5700 |
| Bid | 0.5163 x 400 |
| Ask | 0.5905 x 100 |
| Day's range | 0.5150 - 0.5700 |
| 52-week range | 0.2900 - 1.6700 |
| Volume | |
| Avg. volume | 2,423,940 |
| Market cap | 108.313M |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
RICHMOND, Calif., May 02, 2024--Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
- Business Wire
Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
RICHMOND, Calif., April 22, 2024--Sangamo Therapeutics to Present Neurology Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at ASGCT
- Business Wire
Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
RICHMOND, Calif., March 22, 2024--SANGAMO THERAPEUTICS ANNOUNCES PRICING OF $24.0 MILLION REGISTERED DIRECT OFFERING
© 2024 Yahoo. All rights reserved.